Opendata, web and dolomites

ABOPEN

FIRST INSTANT, OFF-THE-LAB AND USER-FRIENDLY BLOOD GROUPING TEST

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ABOPEN project word cloud

Explore the words cloud of the ABOPEN project. It provides you a very rough idea of what is the project "ABOPEN" about.

world    personal    similarly    eldon    electricity    founding    customers    hdnf    disease    millions    stored    regions    rhesus    fetus    roi    laboratory    generate    overcoming    minute    mothers    15    sold    influential    federation    babies    single    moving    format       transfusions    device    kills    works    worldwide    accidents    instant    rhd    red    deaths    eldoncards    2025    attacks    hdfn    easily    obstretics    women    distributors    eradicated    2002    biologicals    tests    trained    affordability    pioneering    majority    gynecology    prevented    stop    urgent    children    off    limitations    military    procedure    newborn    company    precision    created    network    grouping    profitable    curhe    jobs    keeping    setting    lab    141    pregnancy    danish    dry    immune    220    turnover    hospitals    sizeable    market    despite    screening    cells    24    accuracy    44    international    figo    tested    performed    outside    mother    million    37c    risk    countries    hemolytic    pregnant    months    erase    abopen    blood   

Project "ABOPEN" data sheet

The following table provides information about the project.

Coordinator
ELDON BIOLOGICALS A/S 

Organization address
address: SANDTOFTEN 10
city: GENTOFTE
postcode: 2820
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Project website https://www.eldoncard.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ELDON BIOLOGICALS A/S DK (GENTOFTE) coordinator 50˙000.00

Map

 Project objective

Despite being eradicated from the developed world, the Rhesus Disease or HDFN (Hemolytic Disease of the Fetus and Newborn), a disease where the immune system from the mother attacks the red blood cells from their babies, still kills 141,000 children and mothers in developing regions every year. Deaths that could be easily prevented by screening pregnant women for their RhD factor type. Although 15% of RhD(-) women are at risk, 220 million women in developing countries should be tested, since the majority do not know their RhD factor type. At Eldon Biologicals AS (a Danish company created in 2002), we are a profitable company that has already sold millions of EldonCards (a pioneering off-the-lab dry format grouping test) in more than 44 countries and has built a well-established worldwide network of customers and distributors. We are part of the influential International Federation of Gynecology and Obstretics (FIGO) and founding member of CURhE, an international initiative to stop HDNF. Now, we are moving one step further from EldonCards overcoming its limitations to erase HDNF from developing countries. To do so, we have created ABOPEN, a user-friendly off-the-lab grouping test that can be stored for up to 24 months at 37C and works similarly to pregnancy tests, identifying the RhD factor type in just 1 minute and a single-step procedure. ABOPEN can be performed outside a laboratory setting (does not need electricity) by non-trained personnel, while keeping its affordability (it costs just €4), precision and accuracy. ABOPEN has also a sizeable market in developed countries, as an instant and easy to use device to find out about blood grouping for urgent transfusions (accidents, hospitals, military) or just personal information. By end of 2025, we expect to generate €8 million in turnover (ROI of 2.2), while creating 7 new jobs for the company.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ABOPEN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ABOPEN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

PAROST (2019)

Disruptive technology for the identification, quantification and prediction of the evolution of damages in civil engineering structures that increases safety while reducing maintenance costs.

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More